[Tolerance and effectiveness of oral erythromycin ethyl succinate, intravenous Lactobionate and erythromycin base in infants and small children].
D000284:Administration, Oral; D000469:Alkaline Phosphatase / Q000097:blood; D001663:Bilirubin / Q000097:blood; D002675:Child, Preschool; D002784:Cholesterol / Q000097:blood; D003231:Conjunctivitis / Q000188:drug therapy; D004917:Erythromycin / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D005260:Female; D005690:Galactose / Q000008:administration & dosage; D005942:Gluconates / Q000008:administration & dosage; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007931:Leucyl Aminopeptidase / Q000097:blood; D008111:Liver Function Tests; D008297:Male; D009325:Nausea / Q000139:chemically induced; D010033:Otitis Media / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D013386:Succinates / Q000008:administration & dosage; D013488:Suppositories; D013492:Suppuration; D013997:Time Factors; D000637:Transaminases / Q000097:blood
D005942:Gluconates; D013386:Succinates; D013488:Suppositories; D004917:Erythromycin; D002784:Cholesterol; D000637:Transaminases; D000469:Alkaline Phosphatase; D007931:Leucyl Aminopeptidase; D001663:Bilirubin; D005690:Galactose
Untersuchungen zur Verträglichkeit und Wirksamkeit von Erythromycin-Athylsuccinat oral, Lactobionat i.v. und Erythromycin-Base bei Säuglingen und Kleinkindern.